Neurology Minute
The Neurology Minute podcast delivers a brief daily summary of what you need to know in the field of neurology, the latest science focused on the brain, and timely topics explored by leading neurologists and neuroscienti...
Insights from recent episode analysis
On the show
- Dr. Benjamin P. Trewin2 eps
- Dr. Paulus Rommer2 eps
- Dr. Justin Abbatemarco2 eps
Also: Dr. Stacey Clardy, Dr. Dara Albert, Dr. Scott Perry, Dr. Zohaib Siddiqi, Dr. Laurence Poirier, Casey Kozak, Dr. Andy Southerland, Dr. Layne Dylla, Dr. Alison Christy, Ayesha Sohail, Dr. Natalia Rost, Dr. Derek Stitt, Dr. Jennifer Morganroth, Sukhun Kang, Dr. Margarita Fedorova, Dr. Matthew Robbins, Dr. Chris Boes
Audience Interest
Podcast Focus
Publishing Consistency
Insights are generated by CastFox AI using publicly available data, episode content, and proprietary models.
Most discussed topics
Brands & references
Total monthly reach
Based on 1 signal.
Built from
By chart position
- 🇮🇳India · Mental Health#126505 to 2.7K
- 🇸🇦SA · Mental Health#88158 to 834
- 🇰🇷South Korea · Mental Health#148143 to 757
- 🇧🇪BE · Mental Health#96134 to 708
- 🇯🇵Japan · Mental Health#18891 to 481
- Per-Episode Audience
Est. listeners per new episode within ~30 days
1.2K to 6.3K🎙 Daily cadence·1,000 episodes·Last published yesterday - Monthly Reach
Unique listeners across all episodes (30 days)
4.0K to 21K🇺🇸71%🇮🇳12%🇸🇦4%+6 more - Active Followers
Loyal subscribers who consistently listen
2.2K to 12K
Market Insights
Platform Distribution
Reach across major podcast platforms, updated hourly
Total Followers
—
Total Plays
—
Total Reviews
—
* Data sourced directly from platform APIs and aggregated hourly across all major podcast directories.
| Date | Episode | Topics | Guests | Brands | Places | Keywords | Sponsor | Length | |
|---|---|---|---|---|---|---|---|---|---|
| 10/27/26 | Tolerability, Safety, and Efficacy of Atogepant Versus Topiramate in Adults with Migraine | Dr. Tesha Monteith discusses growing evidence supporting CGRP-targeted therapies as first-line preventive treatment options for people with migraine. Show citation: Reuter U, Dycke AV, Versijpt J, et al. Tolerability, safety, and efficacy of atogepant versus topiramate in adults with migraine (TEMPLE): a randomised, head-to-head, phase 3b trial. Lancet Neurol. 2026;25(9):806-817. doi:10.1016/S1474-4422(26)00214-0 | 2m 18s | ||||||
| 10/26/26 | Rethinking Seronegative NMOSD | Dr. Casey Kozak discusses why most patients referred with seronegative NMOSD ultimately receive alternative diagnoses, underscoring the challenges of accurate diagnosis in antibody-negative cases. Show citation: Lang MV, Welk GM, Tajfirouz DA, et al. Unveiling Misdiagnosis: Rethinking Seronegative NMOSD. Mult Scler. 2025;31(11):1381-1384. doi:10.1177/13524585251360648 | 2m 36s | ||||||
| 10/22/26 | The Menopause Transition and Epilepsy | Dr. Katie Krulisky and Dr. Kelsey Smith discuss the impact of menopause on women with epilepsy, including therapeutics and clinical management during midlife. Show citation: Smith KM, Faubion SS, Vadlamudi L, et al. The Menopause Transition and Epilepsy: A Focus on Therapeutics. Neurol Clin Pract. 2026;16(5):e200650. doi:10.1212/CPJ.0000000000200650 | 1m 39s | ||||||
| 10/21/26 | TRUE-MOGAD Score | Dr. Casey Kozak discusses a new scoring system for MOGAD identification. Show citation: Vilaseca A, Filippatou AG, Said Y, et al. TRUE-MOGAD Score: A Novel Scoring System to Identify MOGAD Among Positive MOG-IgG Test Results. Neurol Neuroimmunol Neuroinflamm. 2026;13(5):e200617. doi:10.1212/NXI.0000000000200617 | 2m 37s | ||||||
| 10/20/26 | Limb Compression Therapy and Chemotherapy-Induced Peripheral Neuropathy in Women With Gynecologic Cancers | Dr. Hailey Katulski discusses limb compression therapy and chemotherapy-induced peripheral neuropathy in women with gynecologic cancers. Show citation: Başkurt K, Uyar GC, Yeşilbaş E, et al. Limb Compression Therapy and Chemotherapy-Induced Peripheral Neuropathy in Women With Gynecologic Cancers: A Prospective Self-Controlled Study(NEURO-GLOVE Trial). Int J Cancer. 2026;159(9):2300-2313. doi:10.1002/ijc.70601 | 3m 41s | ||||||
| 10/19/26 | Delusional Misidentification Syndromes - Part 9 | In the final episode of this nine-part series, Dr. Christine Cliatt-Brown discusses pharmacologic and non-pharmacologic management. | 3m 35s | ||||||
| 10/16/26 | Herpes Zoster Vaccination and Incident Dementia in Canada | Dr. Margarita Fedorova and Dr. Pascal Geldsetzer discuss how the herpes zoster vaccination may have neuroprotective effects, potentially delaying or preventing dementia. Show citation: Pomirchy M, Chung S, Bommer C, Strobel S, Geldsetzer P. Herpes zoster vaccination and incident dementia in Canada: an analysis of natural experiments. Lancet Neurol. 2026;25(2):170-180. doi:10.1016/S1474-4422(25)00455-7 | 2m 35s | ||||||
| 10/15/26 | Understanding the Forces Shaping US Health Care | Dr. Jason Crowell and Dr. John McDonough discuss the historical and economic factors shaping the US healthcare system and why understanding these systemic forces matters for neurologists and patient care. Show citation: Powell A. How to fix U.S. Healthcare? "Radical Action," says John McDonough. Harvard Gazette. August 18, 2026. Accessed August 20, 2026. https://news.harvard.edu/gazette/story/2026/08/how-to-fix-u-s-healthcare-radical-action-says-john-mcdonough/. | 2m 36s | ||||||
| 10/14/26 | Delusional Misidentification Syndromes - Part 8 | In the eighth episode of this nine-part series, Dr. Christine Cliatt-Brown discusses delusional companion syndrome. | 2m 21s | ||||||
| 10/13/26 | Delusional Misidentification Syndromes - Part 7 | In the seventh episode of this nine-part series, Dr. Christine Cliatt-Brown discusses reduplicative paramnesia. | 2m 58s | ||||||
Want analysis for the episodes below?Free for Pro Submit a request, we'll have your selected episodes analyzed within an hour. Free, at no cost to you, for Pro users. | |||||||||
| 10/12/26 | Delusional Misidentification Syndromes - Part 6 | In the sixth episode of this nine-part series, Dr. Christine Cliatt-Brown discusses Cotard syndrome. | 2m 53s | ||||||
| 10/9/26 | Prevalence of CTE at Death in National Football League Players | Dr. Shuvro Roy and Dr. Daniel Daneshvar discussed the prevalence of CTE at death among NFL players and the association between CTE severity and the risk of dementia. Show citation: Daneshvar DH, Nowinski CJ, Abdolmohammadi B, et al. Prevalence of chronic traumatic encephalopathy at death in National Football League players: retrospective population based cohort study, 2008-21. BMJ. 2026;394:e100418. Published 2026 Aug 25. doi:10.1136/bmj-2026-100418 | 1m 59s | ||||||
| 10/8/26 | Clinical Manifestations of Primary CNS T-Cell Lymphoma | Dr. Kait Nevel and Dr. Katharina Schmidbauer discuss primary CNS T-cell lymphoma, highlighting diagnostic challenges, imaging characteristics, and treatment approaches for this rare disease. Show citation: Schmidbauer KJ, Karschnia P, Kaulen LD, et al. Clinical Manifestations of Primary CNS T-Cell Lymphoma: A Retrospective Study of Histopathologic, Molecular, and Neuroimaging Features. Neurol. 2026;106(7):e214744. Published 2026 Mar 17. doi:10.1212/WNL.0000000000214744 | 1m 27s | ||||||
| 10/7/26 | October 2026 President Spotlight: One AAN Community | In the October episode of the President's Spotlight, Dr. Jason Crowell and Dr. Natalia Rost discuss updates on membership options that will help more neurology professionals connect with the AAN. Stay informed by watching the President's Spotlight video. | 3m 11s | ||||||
| 10/6/26 | The Future of Child Neurology Residency Training - Part 2 | In part two of this series, Dr. Dara Albert and Dr. Bruce Cohen highlight the most important takeaways from the task force findings. Show citation: Cohen BH, Gilbert DL, Xixis K, et al. Education Research: The Future of Child Neurology Residency Training: The Perspective of a Child Neurology Society Task Force. Neurol Educ. 2026;5(2):e200331. Published 2026 Jun 12. doi:10.1212/NE9.0000000000200331 | 2m 18s | ||||||
| 10/5/26 | Pharmacologic Treatment for Migraine Prevention in Adults Practice Guideline Recommendations - Part 2 | In the second episode of this two-part series, Dr. Tesha Monteith and Dr. Tamara Pringsheim discuss key take-home messages from the guideline recommendations and share insights on integrating them into clinical practice. Show citation: Potrebic S, Tanveer S, Becker WJ, et al. Pharmacologic Treatment for Migraine Prevention in Adults Practice Guideline Recommendations: Report of the AAN Guidelines Subcommittee and the American Headache Society. Headache. Published online August 31, 2026. doi:10.1111/head.70199 | 1m 43s | ||||||
| 10/2/26 | The Future of Child Neurology Residency Training - Part 1 | In part one of this series, Dr. Dara Albert and Dr. Bruce Cohen discuss why the Child Neurology Society felt it was important to establish a task force to examine child neurology training at this point in time. Show citation: Cohen BH, Gilbert DL, Xixis K, et al. Education Research: The Future of Child Neurology Residency Training: The Perspective of a Child Neurology Society Task Force. Neurol Educ. 2026;5(2):e200331. Published 2026 Jun 12. doi:10.1212/NE9.0000000000200331 | 2m 11s | ||||||
| 10/1/26 | Pharmacologic Treatment for Migraine Prevention in Adults Practice Guideline Recommendations - Part 1 | In the first part of this two-part series, Dr. Tesha Monteith and Dr. Tamara Pringsheim provide a brief overview of the guideline recommendations for pharmacologic treatment of migraine prevention in adults. Show citation: Potrebic S, Tanveer S, Becker WJ, et al. Pharmacologic Treatment for Migraine Prevention in Adults Practice Guideline Recommendations: Report of the AAN Guidelines Subcommittee and the American Headache Society. Headache. Published online August 31, 2026. doi:10.1111/head.70199 | 1m 43s | ||||||
| 9/30/26 | Delusional Misidentification Syndromes - Part 5 | In the fifth episode of this nine-part series, Dr. Christine Cliatt-Brown discusses syndrome of subjective doubles. | 2m 39s | ||||||
| 9/29/26 | Delusional Misidentification Syndromes - Part 4 | In the fourth episode of this nine-part series, Dr. Christine Cliatt-Brown discusses mirrored self-misidentification syndrome. | 3m 17s | ||||||
| 9/28/26 | Delusional Misidentification Syndromes - Part 3 | In the third episode of this nine-part series, Dr. Christine Cliatt-Brown discusses Fregoli syndrome. | 2m 49s | ||||||
| 9/25/26 | Resolution of PML after Treatment with Virus-Specific T Cells and HCT | Dr. Justin Abbatemarco and Dr. Irene Cortese discuss recent advances in the treatment of progressive multifocal leukoencephalopathy (PML), focusing on immune-based therapies like virus-specific T cells and immune checkpoint inhibitors. Show citation: Gonzalez CE, Fletcher A, Jenkins TL, et al. Resolution of PML after Treatment with Virus-Specific T Cells and HCT. N Engl J Med. 2026;394(20):2061-2064. doi:10.1056/NEJMc2514186 | 3m 00s | ||||||
| 9/24/26 | Primary Motor Cortex Involvement and Seizure Risk in Patients With Brain Metastases | Dr. Kait Nevel and Drs. Ayal Aizer and Clara Baselga-Garriga discuss the link between primary motor cortex involvement in brain metastases and increased seizure risk. Show citation: Baselga-Garriga C, Purohit S, Lamba N, et al. Primary Motor Cortex Involvement and Its Association With Seizure Risk in Patients With Brain Metastases. Neurology. 2026;106(7):e214714. doi:10.1212/WNL.0000000000214714 | 4m 36s | ||||||
| 9/23/26 | Delusional Misidentification Syndromes - Part 2 | In part two of this nine-part series, Dr. Christine Cliatt-Brown discusses Capgras syndrome. | 3m 25s | ||||||
| 9/22/26 | Delusional Misidentification Syndromes - Part 1 | In part one of this nine-part series, Dr. Christine Cliatt-Brown provides an overview of delusional misidentification syndromes. | 3m 06s | ||||||
| 7/21/26 | prion diseaseneurology+1 | Dr. Stacey Clardy | American Academy of Neurology | — | human prion diseaseneurology+3 | — | 3m 39s | ||
| 7/20/26 | brain healthadvocacy+3 | Dr. Natalia Rost | AAN | — | AANbrain health+3 | — | 4m 04s | ||
| 7/17/26 | ALSlongitudinal care+3 | Dr. Derek StittDr. Jennifer Morganroth | American Academy of NeurologyPreparing Amyotrophic Lateral Sclerosis Clinics to Provide Longitudinal Care for Individuals Carrying ALS Risk Variants | — | ALSlongitudinal care+5 | — | 2m 42s | ||
| 7/16/26 | drug marketingclinical trials+3 | Dr. Justin AbbatemarcoSukhun Kang | American Academy of NeurologyThe Conversation | — | drug marketingclinical trials+4 | — | 2m 34s | ||
| 7/15/26 | idiopathic normal pressure hydrocephalusDRAIN trial+3 | Dr. Margarita Fedorova | acetazolamideAmerican Academy of Neurology+3 | — | DRAIN trialacetazolamide+3 | — | 3m 44s | ||
| 7/14/26 | headache diagnosisemergency medicine+4 | Dr. Matthew Robbins | American Academy of NeurologyJAMA+1 | — | headachediagnosis+6 | — | 2m 39s | ||
| 7/13/26 | epilepsy carepediatric to adult transition+3 | Dr. Dara AlbertDr. Scott Perry | American Academy of NeurologyAddressing Barriers to Transitioning Pediatric Patients With Epilepsy to Adult Health Care in the United States: A Narrative Review | — | epilepsytransition+5 | — | 2m 21s | ||
| 7/10/26 | neurologymedical journal+3 | Dr. Chris BoesDr. José Merino | NeurologyAmerican Academy of Neurology | — | Neurologymedical journal+3 | — | 2m 12s | ||
| 7/9/26 | epilepsy carepediatric to adult transition+3 | Dr. Dara AlbertDr. Scott Perry | American Academy of NeurologyNeurol Clin Pract+1 | — | epilepsytransition+4 | — | 2m 20s | ||
| 5/5/26 | immunotherapyMOGAD+4 | Dr. Benjamin P. Trewin | rituximabocrelizumab+6 | — | MOGADmaintenance immunotherapy+5 | — | 5m 24s | ||
| 5/4/26 | Epstein-Barr VirusMultiple Sclerosis+3 | Dr. Paulus Rommer | American Academy of NeurologyJAMA Neurol+1 | — | Epstein-Barr VirusMultiple Sclerosis+6 | — | 1m 35s | ||
| 5/1/26 | strokesystemic vasculitis+3 | Dr. Zohaib SiddiqiDr. Laurence Poirier | American Academy of NeurologyNeurology | — | systemic illnessstrokes+3 | — | 2m 10s | ||
| 4/30/26 | Epstein-Barr virusmultiple sclerosis+3 | Dr. Paulus Rommer | JAMA NeurologyAmerican Academy of Neurology+1 | — | Epstein-Barr virusmultiple sclerosis+3 | — | 2m 14s | ||
| 4/29/26 | immunotherapyMOGAD+3 | Dr. Justin AbbatemarcoDr. Benjamin P. Trewin | American Academy of Neurology | — | MOGADimmunotherapy+3 | — | 4m 17s | ||
| 4/28/26 | neuroscience researchfederal funding+3 | — | American Academy of Neurology | — | neurosciencefederal funding+3 | — | 2m 11s | ||
| 4/27/26 | residency applicationneurology+3 | Casey Kozak | American Academy of Neurology | — | neurology residencyapplication process+3 | — | 4m 32s | ||
| 4/24/26 | head CTemergency departments+3 | Dr. Andy SoutherlandDr. Layne Dylla | American Academy of NeurologyTrends in Head CT Use in US Emergency Department Patients From 2007 to 2022: A Nationwide Analysis | — | head CTemergency department+4 | — | 1m 59s | ||
| 4/23/26 | neurologyeducation+4 | Dr. Alison Christy | 2026 Ted Burns Humanism in Neurology Award | — | neurologyhumanism+4 | — | 3m 25s | ||
| 4/22/26 | headache disordersolder adults+3 | Ayesha Sohail | American Academy of NeurologyGlobal Burden of Headache Disorders in Older Adults (Aged ≥ 55 Years) from 1990-2021 | — | headache disordersolder adults+4 | — | 4m 05s | ||
Showing 44 of 1000
Pitch Fit is a Pro feature
See how bookable this show is for guests, which brands already advertise, the per-episode ad value, and the best-fit guest and sponsor profile. The numbers are blurred on the free plan.
How readily this show books outside guests like you.
How proven this show is for host-read sponsorships.
For Guests
ProFor Advertisers
ProUpgrade to Pro to unlock guest cadence, sponsor categories, fit scores, and per-episode ad value for this show.
Chart history for Neurology Minute
Peaked at #88 in SA, currently #88 in SA.
| Market | Genre | Peak | Current | Trend |
|---|---|---|---|---|
| SA | — | #88 | #88 | — |
| BE | — | #96 | #96 | — |
| TH | — | #119 | #119 | — |
| Denmark | — | #125 | #125 | — |
| India | — | #126 | #126 | — |
| HU | — | #129 | #129 | — |
| South Korea | — | #148 | #148 | — |
| Japan | — | #188 | #188 | — |
Chart Positions
8 placements across 8 markets.
Chart Positions
8 placements across 8 markets.